These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2125351)

  • 1. [Clinical usefulness of determining the antibodies to soluble nuclear antigens in various collagen diseases].
    Dziankowska-Bartkowiak B; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Torzecka D; Waszczykowska E
    Przegl Dermatol; 1990; 77(5):332-5. PubMed ID: 2125351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibodies against extractable nuclear antigens. Clinico-biological correlations in 100 cases].
    Barbouch MR; Gorgi Y; Ayed K; Haddad S; Ben Ayed H
    Rev Rhum Mal Osteoartic; 1989 Apr; 56(5):389-94. PubMed ID: 2499031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antibodies to extractable nuclear antigens with counterimmunoelectrophoresis and the Western blot technic].
    Hauke G; Lührmann R; Metz B; Peter HH
    Z Rheumatol; 1988; 47(1):26-9. PubMed ID: 3259356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and differentiation of autoantibodies to extractable nuclear antigens with immunoenzyme tests].
    Horeschi G; Morenz J; Struy H
    Allerg Immunol (Leipz); 1987; 33(4):203-13. PubMed ID: 2449813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
    Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of anti small nuclear ribonucleoprotein antibody in patients with collagen disease--a comparison of sensitivities of four methods].
    Akashi Y; Tokuda M; Kurata N; Yoshizawa N; Takahara J
    Ryumachi; 1995 Jun; 35(3):552-8. PubMed ID: 7570209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies against soluble nuclear antigens in rheumatic diseases].
    Nikolov K; Baleva M
    Vutr Boles; 1987; 26(5):112-7. PubMed ID: 3324484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
    Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
    Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antinuclear antibody screening by an enzyme-linked immunosorbent assay using multiple nuclear antigens].
    Iwata H; Aotsuka S; Okawa M; Kinoshita M; Sumiya M
    Ryumachi; 1997 Aug; 37(4):548-55. PubMed ID: 9311280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
    Morel P; Peltier AP; Allegre P; Civatte J
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2377-80. PubMed ID: 353722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of double immunodiffusion method (ENA-1 test) for detecting anti RNP and/or Sm antibodies].
    Miyawaki S; Sakamoto K; Onodera H
    Rinsho Byori; 1985 Sep; 33(9):1025-30. PubMed ID: 3935834
    [No Abstract]   [Full Text] [Related]  

  • 19. [Descriptive and comparative study of technical methods used for the detection of antinuclear antibodies].
    Abuaf N
    Ann Biol Clin (Paris); 1982; 40(2):65-74. PubMed ID: 6812470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion.
    Deng JS; Bair LW; Medsger TA; Sontheimer RA
    Diagn Clin Immunol; 1987; 5(3):151-7. PubMed ID: 3121208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.